Ensuring Patients' Informed Access to Noninvasive Prenatal Testing
NCT03420274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 691
Last updated 2026-03-02
Summary
Noninvasive prenatal genetic testing (NIPT) is an important new screening test option provided to pregnant women in the first trimester of pregnancy. The advantage of this screen is that is provides information about the risk of trisomy 13, trisomy 18, and trisomy 21 with greater accuracy than conventional screens. At the same time, NIPT can produce information about the risk of a cohort of other fetal genetic variants, including sex chromosome aneuploidies and microdeletion syndromes. While not yet clinically available for whole exome sequencing, the potential for this next clinical application already exists. The challenge is that, while this is an important new test, there are little data about how to best structure patient-centered decisions about NIPTs use, including decisions if to use this screen and how the information may directly inform subsequent prenatal care decisions. The purpose of this study is to gain formative data about current practice patterns with respect to how NIPT is discussed in the clinical visit and to use these data to help inform best practices for NIPTs continued use in the clinical setting.
Conditions
- Genetic Disease
- Genetic Syndrome
- Prenatal Disorder
- Prenatal Maternal Abnormality
- Pregnancy Complications
Interventions
- BEHAVIORAL
-
NEST
This is a point-of-care shared decision-making instrument.
- BEHAVIORAL
-
Usual care
This group will utilize usual care with respect to healthcare provider practice for education and counseling.
Sponsors & Collaborators
-
Indiana University
collaborator OTHER -
National Human Genome Research Institute (NHGRI)
collaborator NIH -
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Ruth M Farrell, M.D., M.A. · The Cleveland Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-19
- Primary Completion
- 2022-04-30
- Completion
- 2023-06-15
Countries
- United States
Study Locations
More Related Trials
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Noninvasive Prenatal Testing
NCT02586428 ·Status: TERMINATED
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD)
NCT05076734 ·Status: COMPLETED ·Phase: NA
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
NCT05502510 ·Status: COMPLETED
-
Study of High Risk Non Invasive Prenatal Test Population
NCT04737070 ·Status: UNKNOWN
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Prevalence of Ambivalence Regarding Prenatal Testing
NCT00342069 ·Status: COMPLETED
-
Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies
NCT03200041 ·Status: COMPLETED ·Phase: NA
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
NCT01708746 ·Status: COMPLETED
-
Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
NCT00006445 ·Status: UNKNOWN ·Phase: NA
-
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NCT03831256 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Non Invasive Prenatal Testing of Down Syndrome
NCT02127515 ·Status: COMPLETED ·Phase: NA
-
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
NCT06147414 ·Status: RECRUITING
-
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
NCT02787486 ·Status: COMPLETED
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
NCT05004337 ·Status: COMPLETED
-
Shifting Options Study
NCT07225595 ·Status: ACTIVE_NOT_RECRUITING
-
Early PrEgnancy Complications Testing
NCT04079361 ·Status: RECRUITING ·Phase: NA
-
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NCT05618431 ·Status: RECRUITING ·Phase: NA
-
VAlidation of a Lower Cost aneUploidy scrEen
NCT03087357 ·Status: COMPLETED